These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 7736452)
21. Experimental study of argon-dye laser photoradiation therapy on tumor-bearing mice. Jeng YS; Chen PH; Wong WK; Yang LL Taiwan Yi Xue Hui Za Zhi; 1988 Jun; 87(6):589-94. PubMed ID: 2971781 [No Abstract] [Full Text] [Related]
22. [History of photodynamic therapy--past, present and future]. Kato H Gan To Kagaku Ryoho; 1996 Jan; 23(1):8-15. PubMed ID: 8546474 [TBL] [Abstract][Full Text] [Related]
23. Photodynamic therapy of endobronchial and esophageal tumors: an overview. McCaughan JS J Clin Laser Med Surg; 1996 Oct; 14(5):223-33. PubMed ID: 9612187 [TBL] [Abstract][Full Text] [Related]
24. A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy. Qiu H; Kim MM; Penjweini R; Finlay JC; Busch TM; Wang T; Guo W; Cengel KA; Simone CB; Glatstein E; Zhu TC Photochem Photobiol; 2017 Jul; 93(4):1115-1122. PubMed ID: 28083883 [TBL] [Abstract][Full Text] [Related]
25. [Photodynamic therapy (PDT) in roentgenographically occult lung cancer by photofrin II and excimer dye laser]. Furuse K; Okunaka T; Sakai H; Konaka C; Kato H; Aoki M; Wada H; Nakamura S; Horai T; Kubota K Gan To Kagaku Ryoho; 1993 Aug; 20(10):1369-74. PubMed ID: 8346935 [TBL] [Abstract][Full Text] [Related]
26. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy. Sitnik TM; Henderson BW Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590 [TBL] [Abstract][Full Text] [Related]
27. Cross-resistance to photofrin-mediated photodynamic therapy and UV light and recovery from photodynamic therapy damage in Rif-8A mouse fibrosarcoma cells measured using viral capacity. DiProspero L; Singh G; Wilson BC; Rainbow AJ J Photochem Photobiol B; 1997 Apr; 38(2-3):143-51. PubMed ID: 9203375 [TBL] [Abstract][Full Text] [Related]
28. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors. Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671 [TBL] [Abstract][Full Text] [Related]
30. A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group. Furuse K; Fukuoka M; Kato H; Horai T; Kubota K; Kodama N; Kusunoki Y; Takifuji N; Okunaka T; Konaka C J Clin Oncol; 1993 Oct; 11(10):1852-7. PubMed ID: 8410109 [TBL] [Abstract][Full Text] [Related]
31. Longer term assessment of photodynamic therapy for intimal hyperplasia: a pilot study. Cheung J; Todd M; Turnbull R; Allison B; Mornin L; Carvalho AM; Spurr G; Hsiang Y J Photochem Photobiol B; 2004 Feb; 73(3):141-7. PubMed ID: 14975402 [TBL] [Abstract][Full Text] [Related]
33. In vivo relaxation time measurements on a murine tumor model--prolongation of T1 after photodynamic therapy. Liu YH; Hawk RM; Ramaprasad S Magn Reson Imaging; 1995; 13(2):251-8. PubMed ID: 7739367 [TBL] [Abstract][Full Text] [Related]
34. Photodynamic therapy in the treatment of subcutaneously implanted human bladder tumour. Han WR; Hill JS; Stylli SS; Kaye AH Aust N Z J Surg; 1992 Aug; 62(8):643-9. PubMed ID: 1642585 [TBL] [Abstract][Full Text] [Related]
35. [Photodynamic therapy with hematoporphyrin derivative for transitional-cell carcinoma of the urinary bladder--report of 30 cases]. Tian ME Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):304-6. PubMed ID: 2533889 [TBL] [Abstract][Full Text] [Related]
36. Photodynamic therapy using intra-articular Photofrin for murine MRSA arthritis: biphasic light dose response for neutrophil-mediated antibacterial effect. Tanaka M; Kinoshita M; Yoshihara Y; Shinomiya N; Seki S; Nemoto K; Hamblin MR; Morimoto Y Lasers Surg Med; 2011 Mar; 43(3):221-9. PubMed ID: 21412806 [TBL] [Abstract][Full Text] [Related]
37. Photofrin-mediated photodynamic therapy for treatment of aggressive head and neck nonmelanomatous skin tumors in elderly patients. Gayl Schweitzer V Laryngoscope; 2001 Jun; 111(6):1091-8. PubMed ID: 11404627 [TBL] [Abstract][Full Text] [Related]
38. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group. Nseyo UO; Shumaker B; Klein EA; Sutherland K J Urol; 1998 Jul; 160(1):39-44. PubMed ID: 9628601 [TBL] [Abstract][Full Text] [Related]
39. Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF. Gołab J; Wilczyński G; Zagozdzon R; Stokłosa T; Dabrowska A; Rybczyńska J; Wasik M; Machaj E; Ołda T; Kozar K; Kamiński R; Giermasz A; Czajka A; Lasek W; Feleszko W; Jakóbisiak M Br J Cancer; 2000 Apr; 82(8):1485-91. PubMed ID: 10780531 [TBL] [Abstract][Full Text] [Related]
40. Photodynamic activity of lutetium-texaphyrin in a mouse tumor system. Hammer-Wilson MJ; Ghahramanlou M; Berns MW Lasers Surg Med; 1999; 24(4):276-84. PubMed ID: 10327046 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]